Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia

Haematologica

Volumn 92, Issue 4, 2007, Pages 450-459

  Juarez, Julius ^a   Baraz, Rana ^a   Gaundar, Shivashni ^a   Bradstock, Kenneth ^b   Bendall, Linda ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

B lineage acute lymphoblastic leukemia; CXCL12; Interleukin 3; Interleukin 7; Proliferation

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 7; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AKT1 PROTEIN, HUMAN; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CHROMONE DERIVATIVE; IMIDAZOLE DERIVATIVE; MORPHOLINE DERIVATIVE; PYRIDINE DERIVATIVE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CANCER STEM CELL; CELL LINEAGE; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; CULTURE MEDIUM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; APOPTOSIS; B CELL LEUKEMIA; BLOOD CELL; BONE MARROW CELL; CELL CULTURE; CELL DIVISION; COCULTURE; DRUG EFFECT; DRUG POTENTIATION; INFANT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PRESCHOOL CHILD; PROTEIN PROCESSING; STROMA CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADOLESCENT; APOPTOSIS; B-LYMPHOCYTES; BLOOD CELLS; BONE MARROW CELLS; CELL DIVISION; CELL SURVIVAL; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; CHROMONES; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; DRUG SYNERGISM; FEMALE; HUMANS; IMIDAZOLES; INFANT; INTERLEUKIN-3; INTERLEUKIN-7; LEUKEMIA, PRE-B-CELL; MALE; MAP KINASE SIGNALING SYSTEM; MORPHOLINES; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 34447131774     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10621     Document Type: Article

References (47)

1. Manabe A, Coustan-Smith E, Behm F, Raimondi S, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79:2370-7.
2. Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y, et al. Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 1997; 89:3735-44.
3. Wormann B, Gesner T, Mufson R, LeBien T. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia 1989;3:399-404.
4. Makrynikola V, Kabral A, Bradstock KF. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells. Exp Hematol 1991;19:674-9.
5. Eder M, Hemmati P, Kalina U, Ottman O, Hoelzer D, Lyman S, et al. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells. Exp Hematol 1996; 24:371-7.
6. Eder M, Ottmann O, Hansen-Hagge T, Bartram C, Gillis S, Hoelzer D, et al. Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia. Leukemia 1990; 4:533-40.
7. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-3.
8. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 1994;91:2305-9.
9. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann NY Acad Sci 2001;938:83-95.
10. Tokoyoda K, Egawa T, Sugiyama T, Choi B, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004;20:707-18.
11. Burger J, Tsukada N, Burger M, Zvaifler N, Dell'Aquila M, Kipps T. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000;96:2655-63.
12. Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin s lymphoma. Cancer Res 2002;62:3106-12.
13. Juarez J, Bradstock K, Gottlieb D, Bendall L. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 2003;17:1294-300.
14. Hodohara K, Fujii N, Yamamoto N, Kaushansky K. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 2000; 95:769-75.
15. Lataillade J, Clay D, Dupuy C, Rigal S, Jasmin C, Bourin P, et al. Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000; 95:756:68.
16. Lataillade J, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C, et al. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34+ cells: evidence for an autocrine/paracrine mechanism. Blood 2002;99:1117-29.
17. Broxmeyer H, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, et al. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 2003;170:421-9.
18. Broxmeyer H, Kohli L, Kim C, Lee Y, Mantel C, Cooper S, et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Galphai proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 2003;73:630-8.
19. Cashman J, Clark-Lewis I, Eaves A, Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 2002;99:792-9.
20. Nishii K, Katayama N, Miwa H, Shikami M, Masuya M, Shiku H, et al. Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein. Br J Haematol 1999;105:701-10.
21. Lee Y, Gotoh A, Kwon H, You M, Kohli L, Mantel C, et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 2002;99:4307-17.
22. Dadi H, Ke S, Roifman C. Interleukin 7 receptor mediates the activation of phosphatidylinositol-3 kinase in human B-cell precursors. Biochem Biophys Res Commun 1993;192:459-64.
23. Bendall LJ, Kortlepel K, Gottlieb DJ. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of b1 and b2 integrin mechanisms. Blood 1993;82:3125-32.
24. Mihara K, Imai C, Coustan-Smith E, Dome J, Dominici M, Vanin E, et al. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 2003;120:846-9.
25. Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 1994;22:1252-60.
26. Kortlepel K, Bendall LJ, Gottlieb DJ. Adhesion molecule expression on human myeloid leukemic cells: regulation by growth factors. Leukemia 1993;7:1174-9.
27. Chen W, Jayawickreme C, Watson C, Wolfe L, Holmes W, Ferris R, et al. Recombinant human CXC-chemokine receptor-4 in melanophores are linked to Gi protein: seven transmembrane coreceptors for human immunodeficiency virus entry into cells. Mol Pharmacol 1998;53:177-81.
28. Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. Cancer 2005; 103:1054-63.
29. Huchet A, Belkacemi Y, Frick J, Prat M, Muresan-Kloos I, Altan D, et al. Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:508-15.
30. Spagnoli G, Kloth J, Terracciano L, Trutmann M, Chklovskaia E, Remmel E, et al. FLT3 ligand gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens. Int J Cancer 2000;86:238-43.
31. Bendall L, Baraz R, Juarez J, Shen W, Bradstock K. Defective p38 mitogen-activated protein kinase signaling impairs cnemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res 2005;65:3290-8.
32. Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, et al. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75: 2097-101.
33. Smiers F, van Paassen M, Pouwels K, Beishuizen A, Hahlen K, Lowenberg B, et al. Heterogeneity of proliferative responses of human B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells to interleukin 7 (IL-7): no correlation with immunoglobulin gene status and expression of IL-7 receptor or IL-2/IL-4/IL-7 receptor common gamma chain genes. Leukemia 1995;9:1039-45.
34. Masuda M, Hoshino S, Motoji T, Oshimi K, Mizoguchi H. Effects of various cytokines on proliferation of acute lymphoblastic leukemia cells. Leuk Res 1990;14:533-43.
35. Skjonsberg C, Erikstein B, Smeland E, Lie S, Funderud S, Beiske K, et al. Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood 1991;77:2445-50.
36. Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood 1991;78:753-9.
37. Cox C, Evely R, Oakhill A, Pamphilon D, Goulden N, Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004;104:2919-25.
38. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, et al. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 1994;83:758-66.
39. Ashley D, Bol S, Kannourakis G. Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts. Leuk Res 1994;18:337-46.
40. Levy Y, Benlagha K, Buzyn A, Colombel M, Brouet J, Lassoued K. IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis. Clin Exp Immunol 1997;110:329-35.
41. Fukuda S, Broxmeyer H, Pelus L. Flt3-ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1{alpha} (CXCL12)/ CXCR4 axis. Blood 2004;105:3117-26.
42. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, et al. The alpha-chemokine, stromal cell-derived factor-1 alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 1998;273:23169-75.
43. Suzuki Y, Rahman M, Mitsuya H. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 2001;167: 3064-73.
44. Barata J, Silva A, Brandao J, Nadler L, Cardoso A, Boussiotis V. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cellacute lymphoblastic leukemia cells. J Exp Med 2004; 200:659-69.
45. Crawley J, Rawlinson L, Lali F, Page T, Saklatvala J, Foxwell B. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 1997;272:15023-7.
46. Khaled A, Bulavin D, Kittipatarin C, Li W, Alvarez M, Kim K, et al. Cytokine-driven cell cycling is mediated through Cdc25A. J Cell Biol 2005;169:755-63.
47. Rajnavolgyi E, Benbernou N, Rethi B, Reynolds D, Young H, Magocsi M, et al. IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases. Cell Signal 2002; 14:761-9.